Thursday , 7 November 2024
Home Innovation Healthcare FDA OKs Xolair as First Drug for Multiple Food Allergies
Healthcare

FDA OKs Xolair as First Drug for Multiple Food Allergies

Food and Drug Administration

The FDA has greenlit Xolair, a medication developed by Novartis Pharmaceuticals and Genentech, as the first drug for reducing allergic reactions to one or more foods. Xolair is intended for patients aged one year and older with immunoglobulin E (IgE)-mediated food allergies who accidentally ingest triggering foods.

The injectable drug allows patients to tolerate higher amounts of allergens without severe reactions when inadvertently exposed, offering a significant breakthrough in managing food allergies. However, it is crucial to note that Xolair is not a cure and patients must continue avoiding foods they are allergic to.

The FDA emphasized that Xolair is not for immediate emergency treatment of allergic reactions, including anaphylaxis. Patients can take the drug every two to four weeks, depending on various factors, to mitigate the severity of allergic reactions.

The approval is a result of the Phase 3 OUtMATCH study, which assessed Xolair’s safety and efficacy in 168 patients aged 1 to 55 with allergies to peanuts and at least two other foods, such as milk, wheat, or cashews. The most common side effects of Xolair are fever and injection site reactions.

Reshema Kemps-Polanco, an executive at Novartis, described the approval as a “paradigm shift” in managing food allergies. Xolair was initially approved by the FDA in 2003 to treat moderate to severe persistent allergic asthma in patients aged 12 and older. Over the years, it has also been used to treat chronic spontaneous urticaria (chronic hives) and chronic rhinosinusitis with nasal polyps.

Since its approval, Xolair has been used by more than 700,000 patients in the U.S. The FDA granted priority review to Xolair in December, highlighting its importance in addressing allergic reactions to multiple foods.

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Articles

McDonald’s
Healthcare

CDC Links Onions to McDonald’s E. Coli Cases Now at 90

The Centers for Disease Control and Prevention (CDC) announced on Wednesday that...

Packaged Salad Ranks Second in Grocery Sales
Healthcare

Salad Kits and Poultry Recalled Over Listeria Threat

Recent recalls involving salad kits, frozen waffles, and poultry have sparked consumer...

E. Coli Outbreak Sickens Dozens Linked to McDonald's
Healthcare

McDonald’s Resumes Quarter Pounders After E. Coli Clearance

McDonald’s has announced the resumption of its Quarter Pounder burger sales following...

Marburg Virus
Healthcare

Marburg Virus: Germany Negative; Rwanda Outbreak

Health officials confirmed on Wednesday that suspected cases of the deadly Marburg...